FDA advisory committees
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Agency is requesting nominations for non-voting industry representatives to sit on existing Center for Biologics Evaluation & Research and Center for Drug Evaluation & Research advisory committees. Under the FDA Modernization Act, industry representation is required only for newly formed committees. However, FDA said it would add non-voting representatives to existing committees "to keep within the spirit of FDAMA